Cargando…

Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity

BACKGROUND: Endometriosis is a benign gynaecological disease. Abundant bulk of evidence suggests that patients with endometriosis have an immunity dysfunction that enables ectopic endometrial cells to implant and proliferate. Previous studies show that natural killer cells have a pivotal role in the...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Foruria, Iñaki, Santulli, Pietro, Chouzenoux, Sandrine, Carmona, Francisco, Batteux, Frédéric, Chapron, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361401/
https://www.ncbi.nlm.nih.gov/pubmed/25775242
http://dx.doi.org/10.1371/journal.pone.0119961
_version_ 1782361629046865920
author González-Foruria, Iñaki
Santulli, Pietro
Chouzenoux, Sandrine
Carmona, Francisco
Batteux, Frédéric
Chapron, Charles
author_facet González-Foruria, Iñaki
Santulli, Pietro
Chouzenoux, Sandrine
Carmona, Francisco
Batteux, Frédéric
Chapron, Charles
author_sort González-Foruria, Iñaki
collection PubMed
description BACKGROUND: Endometriosis is a benign gynaecological disease. Abundant bulk of evidence suggests that patients with endometriosis have an immunity dysfunction that enables ectopic endometrial cells to implant and proliferate. Previous studies show that natural killer cells have a pivotal role in the immune control of endometriosis. METHODS AND FINDINGS: This is a prospective laboratory study conducted in a tertiary-care university hospital between January 2011 and April 2013. We investigated non-pregnant, younger than 42-year-old patients (n= 202) during surgery for benign gynaecological conditions. After complete surgical exploration of the abdominopelvic cavity, 121 women with histologically proven endometriosis and 81 endometriosis-free controls women were enrolled. Patients with endometriosis were classified according to a surgical classification in three different types of endometriosis: superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE). Peritoneal fluid samples were obtained from all study participants during the surgery in order to detect soluble NKG2D ligands (MICA, MICB and ULBP-2). When samples with undetectable peritoneal fluid levels of MICA, MICB and ULBP-2 were excluded, MICA ratio levels were significantly higher in endometriosis patients than in controls (median, 1.1 pg/mg; range, 0.1–143.5 versus median, 0.6 pg/mg; range, 0.1–3.5; p=0.003). In a similar manner peritoneal fluid MICB levels were also increased in endometriosis-affected patients compared with disease-free women (median, 4.6 pg/mg; range, 1.2–4702 versus median, 3.4 pg/mg; range, 0.7–20.1; p=0.001). According to the surgical classification, peritoneal fluid soluble MICA, MICB and ULBP-2 ratio levels were significantly increased in DIE as compared to controls (p=0.015, p=0.003 and p=0.045 respectively). MICA ratio levels also correlated with dysmenorrhea (r=0.232; p=0.029), total rAFS score (r=0.221; p=0.031) and adhesions rAFS score (r=0.221; p=0.031). CONCLUSIONS: We demonstrate a significant increase of peritoneal fluid NKG2D ligands in women with endometriosis especially in those cases presenting DIE. This study suggests that NKG2D ligands shedding is a novel pathway in endometriosis complex pathogenesis that impairs NK cell function.
format Online
Article
Text
id pubmed-4361401
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43614012015-03-23 Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity González-Foruria, Iñaki Santulli, Pietro Chouzenoux, Sandrine Carmona, Francisco Batteux, Frédéric Chapron, Charles PLoS One Research Article BACKGROUND: Endometriosis is a benign gynaecological disease. Abundant bulk of evidence suggests that patients with endometriosis have an immunity dysfunction that enables ectopic endometrial cells to implant and proliferate. Previous studies show that natural killer cells have a pivotal role in the immune control of endometriosis. METHODS AND FINDINGS: This is a prospective laboratory study conducted in a tertiary-care university hospital between January 2011 and April 2013. We investigated non-pregnant, younger than 42-year-old patients (n= 202) during surgery for benign gynaecological conditions. After complete surgical exploration of the abdominopelvic cavity, 121 women with histologically proven endometriosis and 81 endometriosis-free controls women were enrolled. Patients with endometriosis were classified according to a surgical classification in three different types of endometriosis: superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE). Peritoneal fluid samples were obtained from all study participants during the surgery in order to detect soluble NKG2D ligands (MICA, MICB and ULBP-2). When samples with undetectable peritoneal fluid levels of MICA, MICB and ULBP-2 were excluded, MICA ratio levels were significantly higher in endometriosis patients than in controls (median, 1.1 pg/mg; range, 0.1–143.5 versus median, 0.6 pg/mg; range, 0.1–3.5; p=0.003). In a similar manner peritoneal fluid MICB levels were also increased in endometriosis-affected patients compared with disease-free women (median, 4.6 pg/mg; range, 1.2–4702 versus median, 3.4 pg/mg; range, 0.7–20.1; p=0.001). According to the surgical classification, peritoneal fluid soluble MICA, MICB and ULBP-2 ratio levels were significantly increased in DIE as compared to controls (p=0.015, p=0.003 and p=0.045 respectively). MICA ratio levels also correlated with dysmenorrhea (r=0.232; p=0.029), total rAFS score (r=0.221; p=0.031) and adhesions rAFS score (r=0.221; p=0.031). CONCLUSIONS: We demonstrate a significant increase of peritoneal fluid NKG2D ligands in women with endometriosis especially in those cases presenting DIE. This study suggests that NKG2D ligands shedding is a novel pathway in endometriosis complex pathogenesis that impairs NK cell function. Public Library of Science 2015-03-16 /pmc/articles/PMC4361401/ /pubmed/25775242 http://dx.doi.org/10.1371/journal.pone.0119961 Text en © 2015 González-Foruria et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
González-Foruria, Iñaki
Santulli, Pietro
Chouzenoux, Sandrine
Carmona, Francisco
Batteux, Frédéric
Chapron, Charles
Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity
title Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity
title_full Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity
title_fullStr Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity
title_full_unstemmed Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity
title_short Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity
title_sort soluble ligands for the nkg2d receptor are released during endometriosis and correlate with disease severity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361401/
https://www.ncbi.nlm.nih.gov/pubmed/25775242
http://dx.doi.org/10.1371/journal.pone.0119961
work_keys_str_mv AT gonzalezforuriainaki solubleligandsforthenkg2dreceptorarereleasedduringendometriosisandcorrelatewithdiseaseseverity
AT santullipietro solubleligandsforthenkg2dreceptorarereleasedduringendometriosisandcorrelatewithdiseaseseverity
AT chouzenouxsandrine solubleligandsforthenkg2dreceptorarereleasedduringendometriosisandcorrelatewithdiseaseseverity
AT carmonafrancisco solubleligandsforthenkg2dreceptorarereleasedduringendometriosisandcorrelatewithdiseaseseverity
AT batteuxfrederic solubleligandsforthenkg2dreceptorarereleasedduringendometriosisandcorrelatewithdiseaseseverity
AT chaproncharles solubleligandsforthenkg2dreceptorarereleasedduringendometriosisandcorrelatewithdiseaseseverity